
KURA Valuation
Kura Oncology Inc
$
5.770
- Overview
- Forecast
- Valuation
KURA Relative Valuation
KURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KURA is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.06
P/B
Median3y
2.33
Median5y
2.70
27.76
FCF Yield
Median3y
-11.29
Median5y
-9.44
Competitors Valuation Multiple
The average P/S ratio for KURA's competitors is 6.17, providing a benchmark for relative valuation. Kura Oncology Inc Corp (KURA) exhibits a P/S ratio of 3.60, which is -41.71% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
People Also Watch

AVO
Mission Produce Inc
9.960
USD
+2.26%

MRNO
Murano Global Investments Plc
9.080
USD
-4.42%

BXC
Bluelinx Holdings Inc
71.550
USD
+0.76%

AVAH
Aveanna Healthcare Holdings Inc
4.490
USD
-6.46%

GDEN
Golden Entertainment Inc
25.120
USD
-1.49%

ABCL
Abcellera Biologics Inc
2.400
USD
+15.94%

COGT
Cogent Biosciences Inc
4.260
USD
+5.97%

DMRC
Digimarc Corp
11.540
USD
-0.77%

FMBH
First Mid Bancshares Inc
31.020
USD
-0.39%

CRSR
Corsair Gaming Inc
6.190
USD
+0.49%
FAQ

Is Kura Oncology Inc (KURA) currently overvalued or undervalued?
Kura Oncology Inc (KURA) is now in the Fair zone, suggesting that its current forward PS ratio of 3.60 is considered Fairly compared with the five-year average of 50.63. The fair price of Kura Oncology Inc (KURA) is between to according to relative valuation methord.

What is Kura Oncology Inc (KURA) fair value?

How does KURA's valuation metrics compare to the industry average?

What is the current P/B ratio for Kura Oncology Inc (KURA) as of Apr 12 2025?

What is the current FCF Yield for Kura Oncology Inc (KURA) as of Apr 12 2025?

What is the current Forward P/E ratio for Kura Oncology Inc (KURA) as of Apr 12 2025?
